glucose, (beta-d)-isomer has been researched along with Diabetic Retinopathy in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (50.00) | 24.3611 |
| 2020's | 9 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hanaguri, J; Kushiyama, A; Kushiyama, S; Nagaoka, T; Watanabe, M; Yamagami, S; Yokota, H | 1 |
| Herat, L; Matthews, J; Matthews, VB; Rakoczy, E; Rooney, J; Schlaich, M | 1 |
| Ding, L; Jiang, X; Peng, Z; Qiu, L; Xia, X; Yao, F; Zheng, W | 1 |
| Bello, E; Bhatwadekar, AD; Dhami, H; Leley, SP; Luo, Q; Mathew, D | 1 |
| Fang, J; Gong, Q; Sun, J; Sun, Q; Wang, H; Wei, F; Zhang, J; Zhang, R | 1 |
| Li, R; Liu, Y; Tan, CP; Xu, YJ; Yang, W; Ye, Z | 1 |
| Agafonova, A; Anfuso, CD; Cosentino, A; Giurdanella, G; Longo, A; Lupo, G; Rusciano, D | 1 |
| Hua, Z; Li, Y; Ma, X; Yang, J; Zheng, Z; Zhu, L | 1 |
| Li, G; Lu, L; Zhou, H; Zhou, M; Zhu, L | 1 |
| Fan, YX; Hao, MJ; Hu, L; Li, QP; Liu, BQ; Liu, WT; Qian, C; Teng, P; Yuan, ZL; Zhou, XW; Zhu, SH | 1 |
| Angayarkanni, N; Shanmuganathan, S | 1 |
| Alperin, P; Cohen, M; Dziuba, J; Goswami, D; Grossman, HL; Hardy, E; Iloeje, U; Perlstein, I; Racketa, J | 1 |
| Jo, K; Kim, CS; Kim, J; Kim, JS; Lee, YM; Sohn, E; Yoo, NH | 1 |
| Hayashizaki, Y; Takakura, S; Takasu, T; Toyoshi, T | 1 |
| Lei, H; Liu, J; Mei, Y; Ni, N; Niu, B; Wang, J; Xu, J; Yang, X | 1 |
| Fu, W; Gao, X; Hao, X; Ke, X; Ma, N; Wang, W; Wu, J; Zhang, H; Zhang, Z; Zhao, M | 1 |
| Li, CW; Li, ZH; Lu, LC; Luo, MH; Xie, H; Yu, CP; Zhou, W | 1 |
| Cui, X; Li, W; Li, X; Sun, X; Wang, J; Yang, J; Zhu, Q | 1 |
1 trial(s) available for glucose, (beta-d)-isomer and Diabetic Retinopathy
| Article | Year |
|---|---|
Acetagastrodin effects on retinal oscillatory potentials in patients during the early stages of diabetes.
Topics: Adult; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Double-Blind Method; Electroretinography; Female; Glucosides; Hemoglobins; Humans; Male; Middle Aged; Neuroprotective Agents; Prospective Studies; Retina; Wavelet Analysis | 2017 |
17 other study(ies) available for glucose, (beta-d)-isomer and Diabetic Retinopathy
| Article | Year |
|---|---|
The Effect of Sodium-Dependent Glucose Cotransporter 2 Inhibitor Tofogliflozin on Neurovascular Coupling in the Retina in Type 2 Diabetic Mice.
Topics: Animals; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Glucosides; Hypoglycemic Agents; Male; Mice; Mice, Inbred C57BL; Neurovascular Coupling; Retina; Sodium-Glucose Transport Proteins; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Vascular Endothelial Growth Factor A | 2022 |
Determining the role of SGLT2 inhibition with Empagliflozin in the development of diabetic retinopathy.
Topics: Animals; Benzhydryl Compounds; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Glucosides; Humans; Mice; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2022 |
Long-Term Oral Administration of Salidroside Alleviates Diabetic Retinopathy in db/db Mice.
Topics: Administration, Oral; Animals; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Glucosides; Mice; Phenols | 2022 |
Dapagliflozin protects neural and vascular dysfunction of the retina in diabetes.
Topics: Animals; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Endothelial Cells; Glucosides; Mice; Retina | 2022 |
SGLT2 inhibitor-empagliflozin treatment ameliorates diabetic retinopathy manifestations and exerts protective effects associated with augmenting branched chain amino acids catabolism and transportation in db/db mice.
Topics: Amino Acids, Branched-Chain; Animals; Benzhydryl Compounds; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Glucosides; Mammals; Mice; Sodium-Glucose Transporter 2 Inhibitors; Tandem Mass Spectrometry | 2022 |
Blueberry Anthocyanins from Commercial Products: Structure Identification and Potential for Diabetic Retinopathy Amelioration.
Topics: Anthocyanins; Blueberry Plants; Diabetes Mellitus; Diabetic Retinopathy; Glucosides; Molecular Docking Simulation; NF-E2-Related Factor 2; Tandem Mass Spectrometry | 2022 |
Antioxidant Activity of Cyanidin-3-O-Glucoside and Verbascoside in an
Topics: Antioxidants; Diabetes Mellitus; Diabetic Retinopathy; Endothelial Cells; Glucose; Glucosides; Humans; Reactive Oxygen Species | 2022 |
Acteoside inhibits high glucose-induced oxidative stress injury in RPE cells and the outer retina through the Keap1/Nrf2/ARE pathway.
Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Glucose; Glucosides; Kelch-Like ECH-Associated Protein 1; Mice; NF-E2-Related Factor 2; Oxidative Stress; Polyphenols; Reactive Oxygen Species; Retina; Superoxide Dismutase | 2023 |
Arctiin attenuates high glucose-induced human retinal capillary endothelial cell proliferation by regulating ROCK1/PTEN/PI3K/Akt/VEGF pathway in vitro.
Topics: Biomarkers; Cell Cycle Checkpoints; Cell Proliferation; Diabetic Retinopathy; Endothelial Cells; Fluorescent Antibody Technique; Furans; Glucose; Glucosides; Humans; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Retinal Vessels; rho-Associated Kinases; Signal Transduction; Vascular Endothelial Growth Factor A | 2020 |
Paeoniflorin Suppressed High Glucose-Induced Retinal Microglia MMP-9 Expression and Inflammatory Response via Inhibition of TLR4/NF-κB Pathway Through Upregulation of SOCS3 in Diabetic Retinopathy.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Diabetic Retinopathy; Glucose; Glucosides; Inflammation; Matrix Metalloproteinase 9; Mice; Microglia; Monoterpenes; NF-kappa B; Retina; Suppressor of Cytokine Signaling 3 Protein; Toll-Like Receptor 4 | 2017 |
Chebulagic acid and Chebulinic acid inhibit TGF-β1 induced fibrotic changes in the chorio-retinal endothelial cells by inhibiting ERK phosphorylation.
Topics: Animals; Benzopyrans; Binding Sites; Cell Movement; Cell Proliferation; Cells, Cultured; Choroid; Diabetic Retinopathy; Endothelial Cells; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Glucosides; Hydrolyzable Tannins; Macaca mulatta; Molecular Docking Simulation; Neovascularization, Pathologic; Phosphorylation; Plant Extracts; Protein Binding; Receptors, Transforming Growth Factor beta; Retinal Vessels; Signal Transduction; Transforming Growth Factor beta1 | 2019 |
Modeling effects of SGLT-2 inhibitor dapagliflozin treatment versus standard diabetes therapy on cardiovascular and microvascular outcomes.
Topics: Amputation, Surgical; Benzhydryl Compounds; Blood Glucose; Blood Pressure; Body Weight; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Retinopathy; Disease Progression; Glucosides; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Incidence; Kidney Failure, Chronic; Metformin; Microcirculation; Middle Aged; Myocardial Infarction; Nutrition Surveys; Sodium-Glucose Transporter 2 Inhibitors; Stroke; Sulfonylurea Compounds; Thiazolidinediones; Treatment Outcome; Uric Acid | 2014 |
OSSC1E-K19, a novel phytochemical component of Osteomeles schwerinae, prevents glycated albumin-induced retinal vascular injury in rats.
Topics: Animals; Biphenyl Compounds; Collagen; Diabetic Retinopathy; Drug Evaluation, Preclinical; Glucosides; Glycated Serum Albumin; Glycation End Products, Advanced; Male; Plant Extracts; Rats, Sprague-Dawley; Retinal Vessels; Rosaceae; Serum Albumin; Tight Junctions; Vascular Endothelial Growth Factor A | 2015 |
Effect of ipragliflozin, an SGLT2 inhibitor, on progression of diabetic microvascular complications in spontaneously diabetic Torii fatty rats.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Disease Progression; Glucosides; Hyperglycemia; Hypoglycemic Agents; Male; Rats; Rats, Sprague-Dawley; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes | 2016 |
Inhibition of Hypoxia-Induced Retinal Angiogenesis by Specnuezhenide, an Effective Constituent of Ligustrum lucidum Ait., through Suppression of the HIF-1α/VEGF Signaling Pathway.
Topics: Angiogenesis Inhibitors; Animals; Cell Hypoxia; Cell Line; Cobalt; Diabetic Retinopathy; Disease Models, Animal; Epithelial Cells; Gene Expression Regulation; Glucosides; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Inducible Factor-Proline Dioxygenases; Indazoles; Ligustrum; Plant Extracts; Pyrans; Rats; Rats, Sprague-Dawley; Retinal Neovascularization; Retinal Pigment Epithelium; Signal Transduction; Vascular Endothelial Growth Factor A | 2016 |
Effects of arctiin on streptozotocin-induced diabetic retinopathy in Sprague-Dawley rats.
Topics: Animals; Arctium; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Drugs, Chinese Herbal; Furans; Glucosides; Glycated Hemoglobin; Hypoglycemic Agents; Male; Random Allocation; Rats; Rats, Sprague-Dawley; Seeds; Streptozocin | 2012 |
Rhizome of Anemarrhena asphodeloides counteracts diabetic ophthalmopathy progression in streptozotocin-induced diabetic rats.
Topics: Anemarrhena; Animals; Blood Glucose; Cataract; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Glucosides; Glutathione Peroxidase; Glycation End Products, Advanced; Insulin; Lens, Crystalline; Male; Malondialdehyde; Pericytes; Plant Extracts; Rats; Rats, Wistar; Retina; Rhizome; Sorbitol; Streptozocin; Superoxide Dismutase; Xanthones | 2013 |